Jennifer L. Schehr

Also affiliated with University of Wisconsin Carbone Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “BAF155 methylation drives metastasis by hijacking super-enhancers and subverting anti-tumor immunity”.

BAF155 methylation drives metastasis by hijacking super-enhancers and subverting anti-tumor immunity

Nucleic Acids Research(2021)10.1093/nar/gkab1122

N/A

1.7DataRank · unranked

66 citations

Peng Liu, Shengjie Zhang, Kristine Donahue, Yidan Wang, Jennifer L. Schehr +12 more

Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma

Molecular Oncology(2021)10.1002/1878-0261.12931

N/A

0.959DataRank · unranked

22 citations

Jennifer L. Schehr, Hamid Emamekhoo, Benjamin K. Gibbs, Tamara S. Rodems, Matthew C. Mannino +16 more

Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase 1b Trial

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.11.040

N/A

0.434DataRank · unranked

17 citations

Brett Morris, Nan Sethakorn, Joshua M. Lang, Jennifer L. Schehr, Shuang G. Zhao +9 more

High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1509

N/A

0.425DataRank · unranked

16 citations

Jamie M. Sperger, Amy K. Taylor, Katharine E. Tippins, Shannon R. Reese, V. Carreño +31 more

Fragmentomic analysis of circulating tumor DNA-targeted cancer panels

Annals of Oncology(2023)10.1016/j.annonc.2023.06.001

N/A

0DataRank · unranked

67 citations

Marina N. Sharifi, Jamie M. Sperger, Yue Shi, Matti Annala, Matthew L. Bootsma +29 more

Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

Oncotarget(2023)10.18632/oncotarget.28477

N/A

0DataRank · unranked

7 citations

Bing Yang, Tanaya A. Purohit, Jennifer L. Schehr, Anupama Singh, Marcelo Bigarella +5 more

Prognostic value of integrated liquid biopsies in patients (pts) with metastatic urothelial cancer (mUC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.547

N/A

0DataRank · unranked

1 citations

Hamid Emamekhoo, Katherine R. Kaufmann, Petros Grivas, Moshe Chaim Ornstein, Iris Yeong- Fung Sheng +9 more

Association of emergent neuroendocrine prostate cancer detected by liquid biopsies with survival and treatment resistance.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.247

N/A

0DataRank · unranked

1 citations

Jamie M. Sperger, Marina N. Sharifi, Yue Shi, Charlotte N. Stahlfeld, Jennifer L. Schehr +9 more

Human CD4+iNKT cell adoptive immunotherapy induces anti‐tumour responses against CD1d‐negative EBV‐driven B lymphoma

Immunology(2024)10.1111/imm.13799

N/A

0DataRank · unranked

6 citations

Akshat Sharma, Jennifer L. Schehr, Jayati Basu, Kelsey A. Smith, Makoto Ohashi +4 more

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels

Nature Communications(2025)10.1038/s41467-025-64153-z

N/A

0DataRank · unranked

8 citations

Marina N. Sharifi, Jamie M. Sperger, Matthew R. Chrostek, Matthew L. Bootsma, Shannon R. Reese +22 more

Centrosome amplification is a frequent event in circulating tumor cells from subjects with metastatic breast cancer

Molecular Oncology(2020)10.1002/1878-0261.12687

N/A

0DataRank · unranked

22 citations

Ryan A. Denu, Serena K. Wolfe, Jamie M. Sperger, Jennifer L. Schehr, Tessa Witkowsky +6 more

Microfluidic Characterization and Analysis of Circulating Tumor Cells From Patients With Metastatic Melanoma

Pigment Cell & Melanoma Research(2025)10.1111/pcmr.70030

N/A

0DataRank · unranked

4 citations

Shuang G. Zhao, Benjamin K. Gibbs, Jennifer L. Schehr, Isabella G. Fernandez, Diego Eyzaguirre +8 more

A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer

Journal of Clinical Investigation(2022)10.1172/jci161858

N/A

0DataRank · unranked

33 citations

Jamie M. Sperger, Jennifer L. Schehr, Rana R. McKay, Hamid Emamekhoo, Anupama Singh +34 more

Analytical validation and initial clinical testing of quantitative microscopic evaluation for PD-L1 and HLA I expression on circulating tumor cells from patients with non-small cell lung cancer

Biomarker Research(2022)10.1186/s40364-022-00370-8

N/A

0DataRank · unranked

7 citations

Nan Sethakorn, Zachery D. Schultz, Camila I. Hernandez, Rory M. Bade, Diego Eyzaguirre +10 more

Single cell phenotyping of PDL1 and HLA1 on circulating tumor cells (CTC) in clear cell renal cell carcinoma (ccRCC) on systemic treatment with immunotherapy (IO) and vascular endothelial growth factor receptor tyrosine kinase inhibitors (TKI).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.381

N/A

0DataRank · unranked

0 citations

Matthew C. Mannino, Matthew L. Bootsma, Rory M. Bade, Meghan Wells, Jennifer L. Schehr +5 more